You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 10,512,657


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,512,657 protect, and when does it expire?

Patent 10,512,657 protects LIVMARLI and is included in one NDA.

This patent has seventy-six patent family members in twenty-two countries.

Summary for Patent: 10,512,657
Title:Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
Abstract:Provided herein are methods of treating or ameliorating a pediatric cholestatic liver disease by non-systemically administering to an individual in need thereof a therapeutically effective amount of a pediatric formulation comprising an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating a pediatric liver disease, decreasing the levels of serum bile acids or hepatic bile acids, treating or ameliorating pruritis, reducing liver enzymes, or reducing bilirubin comprising non-systemically administering to an individual in need thereof a therapeutically effective amount of a pediatric formulation comprising an ASBTI or a pharmaceutically acceptable salt thereof.
Inventor(s):Gedulin Bronislava, Grey Michael, "ODonnell Niall"
Assignee:LUMENA PHARMACEUTIALS LLC
Application Number:US15137323
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,512,657

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 10,512,657, focusing on its scope, claims, and the broader patent landscape.

Patent Overview

United States Patent 10,512,657 is associated with Mirum Pharmaceuticals, a company specializing in treatments for rare diseases. The patent is listed in the context of the company's pipeline for various indications, including treatments for Primary Biliary Cholangitis (PBC) and other conditions[4].

Patent Scope

The scope of a patent defines the boundaries of what is protected under the patent. This includes the specific inventions, methods, or products described in the patent claims.

Invention Description

The patent in question pertains to a method of treatment and specific formulations related to the drug volixibat. Volixibat is a bile acid transporter inhibitor used in the treatment of PBC and other bile acid-related disorders. The scope of the patent encompasses the composition of matter, methods of treatment, and specific dosing regimens[4].

Claims Analysis

Patent claims are the legal definitions of the invention and are crucial for determining the scope of protection. Here are some key aspects to consider:

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the composition of volixibat or the method of treating PBC using volixibat.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, dependent claims might specify particular dosages, administration routes, or patient populations.
  • Claim Construction: The interpretation of patent claims is critical for understanding the scope. This involves analyzing the claim language, the specification, and any relevant prosecution history.

Claim Types

The patent likely includes various types of claims:

Composition of Matter Claims

These claims cover the chemical structure or formulation of volixibat. For example:

"A pharmaceutical composition comprising volixibat and a pharmaceutically acceptable carrier."

Method of Treatment Claims

These claims describe the use of volixibat for treating specific conditions. For example:

"A method of treating Primary Biliary Cholangitis, comprising administering volixibat to a patient in need thereof."

Dosing Regimen Claims

These claims specify the dosage and administration schedule of volixibat. For example:

"A method of treating Primary Biliary Cholangitis, comprising administering 5 mg of volixibat once daily to a patient in need thereof."

Patent Landscape

Understanding the broader patent landscape is essential for assessing the patent's strength and potential challenges.

Prior Art

Prior art refers to existing knowledge and patents that predate the current patent. Conducting a thorough search using tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases (such as those provided by the European Patent Office, Japan Patent Office, and World Intellectual Property Organization) can help identify relevant prior art[1].

Patent Family

The patent family includes all related applications filed at participating IP offices. Using the Global Dossier service, one can access the file histories, classification, and citation data for these applications, which helps in understanding the global protection and any office actions[1].

Competitor Patents

Analyzing patents held by competitors in the same field can reveal potential overlaps or gaps in protection. This involves searching patent databases and reviewing the claims and specifications of relevant patents.

Enforcement and Litigation

The enforceability of a patent depends on its validity and the scope of its claims.

Validity Challenges

Patents can be challenged through various mechanisms, such as inter partes review (IPR) or post-grant review (PGR). These processes involve arguing that the patent is invalid due to prior art or other grounds.

Infringement Analysis

To determine if another party is infringing the patent, one must compare the accused product or method against the claims of the patent. This often involves a detailed analysis of the claim language and the specifications.

Market Impact

The market impact of a patent is significant, as it can provide a competitive advantage by excluding others from making, using, or selling the invention.

Exclusivity Period

Patents typically grant exclusivity for a period of 20 years from the filing date. For volixibat, this means that Mirum Pharmaceuticals has exclusive rights to the drug and its methods of treatment during this period, which can be extended under certain conditions[4].

Licensing and Collaboration

Patents can also be licensed to other companies, allowing them to use the invention in exchange for royalties. This can expand the reach of the invention and generate revenue.

Key Takeaways

  • Patent Scope: The scope of a patent defines what is protected and is crucial for determining validity and enforceability.
  • Claims Analysis: Understanding the different types of claims (composition of matter, method of treatment, dosing regimens) is essential for interpreting the patent.
  • Patent Landscape: Analyzing prior art, patent families, and competitor patents helps in assessing the patent's strength and potential challenges.
  • Enforcement and Litigation: Validity challenges and infringement analysis are critical for enforcing the patent.
  • Market Impact: Patents provide exclusivity, which can be a significant competitive advantage.

FAQs

Q: How do I search for existing patents related to my invention? A: You can use the USPTO's Patent Public Search tool, Global Dossier, and other international patent databases to search for existing patents[1].

Q: What is the difference between independent and dependent claims? A: Independent claims stand alone and define the broadest scope of the invention, while dependent claims build upon the independent claims and provide additional details or limitations.

Q: How long does a patent provide exclusivity? A: Patents typically grant exclusivity for a period of 20 years from the filing date.

Q: Can patents be licensed to other companies? A: Yes, patents can be licensed to other companies, allowing them to use the invention in exchange for royalties.

Q: How do I determine if another party is infringing my patent? A: To determine infringement, you must compare the accused product or method against the claims of your patent, often involving a detailed analysis of the claim language and specifications.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Mirum Pharmaceuticals: Transforming Lives in Rare Disease: https://s29.q4cdn.com/633867992/files/doc_presentations/2024/May/31/Mirum-Updated-Corporate-Presentation_May-Update.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,512,657

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mirum LIVMARLI maralixibat chloride SOLUTION;ORAL 214662-001 Sep 29, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTATIS (PFIC) ⤷  Subscribe
Mirum LIVMARLI maralixibat chloride SOLUTION;ORAL 214662-002 Jul 24, 2024 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS 12 MONTHS OF AGE AND OLDER WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,512,657

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2771003 ⤷  Subscribe 2023C/521 Belgium ⤷  Subscribe
European Patent Office 2771003 ⤷  Subscribe 301234 Netherlands ⤷  Subscribe
European Patent Office 2771003 ⤷  Subscribe CA 2023 00017 Denmark ⤷  Subscribe
European Patent Office 2771003 ⤷  Subscribe 122023000029 Germany ⤷  Subscribe
European Patent Office 2771003 ⤷  Subscribe 21/2023 Austria ⤷  Subscribe
European Patent Office 2771003 ⤷  Subscribe CR 2023 00017 Denmark ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.